CN103494904B - One treats neurasthenic Chinese medicine composition - Google Patents
One treats neurasthenic Chinese medicine composition Download PDFInfo
- Publication number
- CN103494904B CN103494904B CN201310467243.1A CN201310467243A CN103494904B CN 103494904 B CN103494904 B CN 103494904B CN 201310467243 A CN201310467243 A CN 201310467243A CN 103494904 B CN103494904 B CN 103494904B
- Authority
- CN
- China
- Prior art keywords
- fructus
- parts
- chinese medicine
- medicine composition
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses one and treat neurasthenic Chinese medicine composition.The traditional Chinese medical science is thought, neurasthenia belongs to " being insomnia ", " cardiopalmus ", " melancholia ", " deficient ", " seminal emission ", the category such as " sexual impotence ", how to be hindered by feelings will, after spiritual hypertonicity or serious disease prolonged illness caused by visceral dysfunction.The present invention selects to have nourishing the liver and kidney, soothing liver-QI for relieving depression, spleen invigorating is regulated the flow of vital energy, replenishing blood for nourishing heart, sedate are calmed the nerves Chinese medicine Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.), Rhizoma et radix valerianae, Lignum Poria, Fructus sarcococcae ruscifoliae, Fructus Rubi obcordati, Herba Crotalariae Ferrugineae, Fructus Akebiae, pulvis ferri (ferrosic oxide), Fructus Melodini Henryi, Herba Ainsliaeae Glabrae, Placenta Hominis, Radix Glycyrrhizae, be brewed into soup and take orally, through clinical observation, total effective rate reaches 92%, and without obvious toxic and side effects.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to one and treat neurasthenic Chinese medicine composition.
Background technology
Neurasthenia is a kind of based on brain and the weak neurosis of somatic function, and to be easy to excited, being easy to again tired is feature, often with the physiological dysfunction symptom such as emotional symptoms and muscle tone pain, sleep disorder such as anxiety, worry, irritability.Clinical manifestation is that patient is often sleepy, sleepy, weak, drowsiness for daytime, and night then has a sleepless night, dreaminess, loses the excitement of normal person and suppression temporal regularity.There are some researches show, work, study hypertonicity are acted hurriedly in a messy situation, and have a rest and sleep and be irregular, operating pressure is large, and health is in sub-health state and emotional instability etc., is to cause neurasthenic main cause.Current western medical treatment neurasthenia mainly relies on the hypnotic sedative dose of treatments such as stable, but these medicines existing defects in safety and dependency, easy addiction, drug resistance, side effect is larger, unsuitable long-term taking.I finds through clinical observation for many years, utilizes treatment by Chinese herbs neurasthenia to have good curative effect.
Summary of the invention
The object of this invention is to provide one and treat neurasthenic Chinese medicine composition.The traditional Chinese medical science is thought, neurasthenia belongs to " being insomnia ", " cardiopalmus ", " melancholia ", " deficient ", " seminal emission ", the category such as " sexual impotence ", how to be hindered by feelings will, after spiritual hypertonicity or serious disease prolonged illness caused by visceral dysfunction.
The object of the invention is to be achieved through the following technical solutions, the neurasthenic Chinese medicine composition of this treatment is made up of the Chinese medicine of following weight portion: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 7-9 part, Rhizoma et radix valerianae 8-10 part, Lignum Poria 6-12 part, Fructus sarcococcae ruscifoliae 8-12 part, Fructus Rubi obcordati 7-9 part, Herba Crotalariae Ferrugineae 7-11 part, Fructus Akebiae 7-9 part, pulvis ferri (ferrosic oxide) 7-12 part, Fructus Melodini Henryi 10-14 part, Herba Ainsliaeae Glabrae 10-14 part, Placenta Hominis 10-14 part, Radix Glycyrrhizae 6-10 part.
Preferred: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 8 parts, Rhizoma et radix valerianae 9 parts, Lignum Poria 9 parts, Fructus sarcococcae ruscifoliae 10 parts, Fructus Rubi obcordati 8 parts, Herba Crotalariae Ferrugineae 9 parts, Fructus Akebiae 8 parts, pulvis ferri (ferrosic oxide) 9.5 parts, Fructus Melodini Henryi 12 parts, Herba Ainsliaeae Glabrae 12 parts, Placenta Hominis 12 parts, 8 parts, Radix Glycyrrhizae.
Preparation method: make decoction by traditional preparation method decocting.
Fang Zhong: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.): tranquillizing and allaying excitement; Rhizoma et radix valerianae: tranquilizing by nourishing the heart, regulate the flow of vital energy, promoting blood circulation and stopping pain; Lignum Poria, Fructus sarcococcae ruscifoliae: nourishing the liver is calmed the nerves; Fructus Rubi obcordati: the kidney invigorating arresting seminal emission; Herba Crotalariae Ferrugineae: gas of astringing the lung, spleen reinforcing kidney; Fructus Akebiae: liver-smoothing, qi-regulating, promoting blood circulation and stopping pain; Pulvis ferri (ferrosic oxide): checking hyperfunction of the liver for relieving convulsion, calm, enrich blood; Fructus Melodini Henryi, Herba Ainsliaeae Glabrae: with blood dissipating blood stasis, yin nourishing; Placenta Hominis: benefiting QI and nourishing blood, the kidney warming mend essence; Radix Glycyrrhizae: in QI invigorating benefit, coordinating the actions of various ingredients in a prescription.
Clinical data
1. 50 routine patients selected by physical data are the neurastheniac of my Out-patient Department and hospitalization, meet the diagnostic criteria that CCMD mono-2-R related neurological is weak, and are difficult to adhere to normal work, studying and living.According to being admitted to hospital, sequencing is divided into two groups at random.Treatment group 25 example, man 15 example, female 10 example; 16 ~ 46 years old age, average 25.3 years old; The course of disease is the shortest 5 months, the longest 4.2 years, average 1.3 ± 0.8 years.Matched group 25 example, man 13 example, female 12 example; Age 16-45 year, average 23.6 years old; The course of disease is the shortest 6 months, the longest 3.6 years, average 1.2 ± 0.65 years.Two groups of data compare without significant difference.Have than can property.
2. all cases of diagnostic criteria are all diagnosed with reference to diagnostic criteria neurasthenic in " neurological ".
3. Therapeutic Method matched group patient gives 1. general treatment: give estazolam 2mg, every day 3 times, and insomnia severe one adds to 4 ~ 6mg night; Oryzanol 20mg, every day 3 times; Piracetam 0.8g, every day 3 times; Depressed person is accompanied to give doxepin 25mg, every day 3 times.2. psychotherapy: the method adopting individual psychotherapy, 1 time weekly, explains the neurasthenic cause of disease, character and prognosis to patient repeatedly, analyze the reason of therapeutic effect difference in the past, by curing advising by citing one's own experience of case, patient is freed one's mind of apprehensions, build confidence, positive partner treatment.Church patient does progressive relaxation training, and every day is 1-2 time.Treatment group adds on matched group basis uses new prescription: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 8g, Rhizoma et radix valerianae 9g, Lignum Poria 9g, Fructus sarcococcae ruscifoliae 10 parts of g, Fructus Rubi obcordati 8g, Herba Crotalariae Ferrugineae 9g, Fructus Akebiae 8g, pulvis ferri (ferrosic oxide) 9.5g, Fructus Melodini Henryi 12g, Herba Ainsliaeae Glabrae 12g, Placenta Hominis 12 parts of g, Radix Glycyrrhizae 8g, decocting becomes juice, instructions about how to take medicine: day potion, decoction being taken warmly at twice, serveing on 7 days was 1 course for the treatment of.
4. criterion of therapeutical effect recovery from illness: clinical symptom disappearance, does not affect normal work and study.Effective: sleep quality improves, appetite increases, and the diseases such as headache, dizziness, fatigue and weak are taken a turn for the better, hypermnesia.Effective: above-mentioned symptom makes moderate progress.Invalid: before and after treatment, clinical symptoms is unchanged.
5. after therapeutic outcome two groups of patients all treat 4 courses for the treatment of, treatment group total effective rate 92% is better than 68% of matched group, and difference has statistical significance (P < 0.05), and concrete Comparison of therapeutic data are in table 1.
Table 1 liang group Comparison of therapeutic
6. untoward reaction: do not find obvious adverse reaction.
Detailed description of the invention
Embodiment one: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 8g, Rhizoma et radix valerianae 9g, Lignum Poria 9g, Fructus sarcococcae ruscifoliae 10 parts, Fructus Rubi obcordati 8g, Herba Crotalariae Ferrugineae 9g, Fructus Akebiae 8g, pulvis ferri (ferrosic oxide) 9.5g, Fructus Melodini Henryi 12g, Herba Ainsliaeae Glabrae 12g, Placenta Hominis 12 parts of g, Radix Glycyrrhizae 8g, makes decoction by traditional preparation method decocting.
Embodiment two: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 7g, Rhizoma et radix valerianae 8g, Lignum Poria 6g, Fructus sarcococcae ruscifoliae 8g, Fructus Rubi obcordati 7g, Herba Crotalariae Ferrugineae 7g, Fructus Akebiae 7g, pulvis ferri (ferrosic oxide) 7g, Fructus Melodini Henryi 10g, Herba Ainsliaeae Glabrae 10, Placenta Hominis 10-g, Radix Glycyrrhizae 6g, makes decoction by traditional preparation method decocting.
Embodiment three: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 9g, Rhizoma et radix valerianae 10g, Lignum Poria 12g, Fructus sarcococcae ruscifoliae 12g, Fructus Rubi obcordati 9g, Herba Crotalariae Ferrugineae 11g, Fructus Akebiae 9g, pulvis ferri (ferrosic oxide) 12g, Fructus Melodini Henryi 14g, Herba Ainsliaeae Glabrae 14g, Placenta Hominis 14g, Radix Glycyrrhizae 10g, makes decoction by traditional preparation method decocting.
Claims (2)
1. treat a neurasthenic Chinese medicine composition, it is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 7-9 part, Rhizoma et radix valerianae 8-10 part, Lignum Poria 6-12 part, Fructus sarcococcae ruscifoliae 8-12 part, Fructus Rubi obcordati 7-9 part, Herba Crotalariae Ferrugineae 7-11 part, Fructus Akebiae 7-9 part, pulvis ferri (ferrosic oxide) 7-12 part, Fructus Melodini Henryi 10-14 part, Herba Ainsliaeae Glabrae 10-14 part, Placenta Hominis 10-14 part, Radix Glycyrrhizae 6-10 part.
2. one according to claim 1 treats neurasthenic Chinese medicine composition, it is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 8 parts, Rhizoma et radix valerianae 9 parts, Lignum Poria 9 parts, Fructus sarcococcae ruscifoliae 10 parts, Fructus Rubi obcordati 8 parts, Herba Crotalariae Ferrugineae 9 parts, Fructus Akebiae 8 parts, pulvis ferri (ferrosic oxide) 9.5 parts, Fructus Melodini Henryi 12 parts, Herba Ainsliaeae Glabrae 12 parts, Placenta Hominis 12 parts, 8 parts, Radix Glycyrrhizae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310467243.1A CN103494904B (en) | 2013-09-23 | 2013-09-23 | One treats neurasthenic Chinese medicine composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310467243.1A CN103494904B (en) | 2013-09-23 | 2013-09-23 | One treats neurasthenic Chinese medicine composition |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103494904A CN103494904A (en) | 2014-01-08 |
CN103494904B true CN103494904B (en) | 2015-07-29 |
Family
ID=49860227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310467243.1A Expired - Fee Related CN103494904B (en) | 2013-09-23 | 2013-09-23 | One treats neurasthenic Chinese medicine composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103494904B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1083719A (en) * | 1993-06-09 | 1994-03-16 | 苏鉴 | Relieving mental strain and helping sleep Chinese patent medicine and preparation method thereof |
USPP19942P2 (en) * | 2008-03-12 | 2009-04-21 | Gurjit Sidhu | Sarcococca plant named ‘Sarsid 1’ |
CN101780159B (en) * | 2010-03-08 | 2011-08-10 | 韩凤珍 | Preparation method of traditional Chinese medicine for treating insomnia with deficiency of both heart-qi and gallbladder-qi |
-
2013
- 2013-09-23 CN CN201310467243.1A patent/CN103494904B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103494904A (en) | 2014-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101264275B (en) | Medicated pillow for treating scapulohumeral periarthritis and cervical spondylosis | |
CN103860912B (en) | One treats neurasthenic Chinese medicine composition | |
CN105194631B (en) | Treat the Chinese medicine preparation of depression | |
CN103705705A (en) | Traditional Chinese medicine composition for treating polymyositis | |
CN103800888B (en) | A kind of Chinese medicine composition treating neurasthenia | |
CN103948708B (en) | A kind of Chinese medicine for the treatment of restless legs syndrome | |
CN103495019B (en) | A kind of tranquilizing by nourishing the heart Chinese medicine preparation and preparation method thereof | |
CN104225450A (en) | Traditional Chinese medicine for treating depression | |
CN103550688B (en) | A kind of Chinese medicine composition for the treatment of cardiopalmus | |
CN102687967A (en) | Hypertension medicinal pillow | |
CN104771652A (en) | Vertigo treating traditional Chinese medicine composition | |
CN103494904B (en) | One treats neurasthenic Chinese medicine composition | |
CN105535849A (en) | Traditional Chinese medicine for treating liver depression insomnia | |
CN104524235A (en) | Traditional Chinese medicine composition for treating cardiac neurosis | |
CN104606650A (en) | Traditional Chinese medicine composition treating insomnia | |
CN104547642A (en) | Tradtional Chinese medicine composition for treating female fibromyalgia syndromes | |
CN103610856A (en) | Traditional Chinese medicine preparation for treating neurasthenia | |
CN104056206A (en) | Refreshing, depression-resolving and tranquilizing preparation | |
CN101653495B (en) | Chinese traditional medicine for curing insomnia | |
CN105943753A (en) | Traditional Chinese medicinal composition for preventing and treating chronic fatigue syndrome | |
CN104258176A (en) | Traditional Chinese medicine preparation for treating vegetative nerve functional disorder | |
CN105833199A (en) | Traditional Chinese medicine composition for treating hysteria | |
CN104524090A (en) | Traditional Chinese medicine preparation for treating sequelae of head injury | |
CN105288149A (en) | Traditional Chinese medicine composition for treating neurasthenia | |
CN104940790A (en) | Traditional Chinese medicine for treating psychoneurosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150729 Termination date: 20150923 |
|
EXPY | Termination of patent right or utility model |